Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.


Sierra Leone vaccinates people quarantined after Ebola death

21 January 2016, 07:58

Freetown - Sierra Leone authorities Wednesday announced a vaccination programme for people quarantined following a new Ebola death last week just as west Africa declared an end to the epidemic.

"Vaccination began yesterday (Tuesday)," in places the victim, a 22-year-old student, visited before her death on January 12 in the northern town of Magburaka, Sierra Leone's head of medical services, doctor Brima Kargbo, told AFP.

He said they were using the VSV-EBOV vaccine, which has already been tested in Guinea -- one of the three countries worst affected by the outbreak, along with Liberia and Sierra Leone -- and was also used in September in a town in northern Sierra Leone under quarantine.

This vaccine is the first to have proven effective, according to experts.

The operation will last "until all the contacts are vaccinated", Kargbo added.

Also Read: Ebola: West Africa’s unfinished business

Since Tuesday, 22 people have been vaccinated in Magburaka and five in Kambia while figures were not yet available for the town of Lunsar, where the dead student usually lived.

According to medical sources, the young woman fell ill at the start of January while on holiday in Baomoi Luma, near the border with Guinea.

The World Health Organization announcement on Friday confirming she had tested positive for Ebola came just a day after west Africa celebrated the end of the outbreak with Liberia becoming the last of the three worst-hit countries in the region to be declared free of the disease.

Among the hundreds of identified contacts, "nobody has shown any sign or symptom of the virus yet," Kargbo said.

In Lunsar, however, some were opposed to receiving the vaccine and had refused to allow health teams into their homes, according to residents.

"Some of those quarantined barricaded their homes saying the vaccine was harmful and could lead to other ailments," one of them said.

The Ebola outbreak, which began in Guinea in December 2013, killed more than 11,000 people and was the deadliest outbreak of the virus yet.



Read more from our Users

Nigeria @ 56: Words to my green f...

A leader’s job is not to dictate, but rather to be respected, admired and be a trustee, of the land we love, with so much potential, a land which should be freer than free. Its still a long way to fufilling our destiny! Read more...

Submitted by
Isaac Asabor263
Recession: An opportunity for Nig...

The recession should be seen as an opportunity for the country’s promotion as long as we all collectively conduct ourselves in a patriotic manner, writes Isaac Asabor.  Read more...

Submitted by
Black and White

We want to imitate the whites in everything because we are ignorant of our inherent originality and content. We spend all our Naira to acquire his inventions because we so oblivious of our natural endowments that we allow him have it for free. Read more...

Submitted by
Nate Nat
Adamawa State University Mubi: A ...

ADSU integrity forum has accused the Sunday Joshua Wugira, a lawyer, of adopting unorthodox tactics by abusing his privilege by attacking the integrity of ADSU Vice Chancellor Dr. Moses Zira Zaruwa, writes a News24 reader. Read more...

Submitted by
Abdulsalam Jubril
My Country Nigeria (Part One)

Poetry by Abdulsalam Jubril.

Submitted by
Abdulsalam Jubril
Recession, dearth in leadership a...

Every leader has the opportunity to become great and making himself immortal in the lives and hearts of people for generations to come. Will Mr. President seize this opportunity?, questions Abdulsalam Jubril. Read more...